Catalyst Wire Dossier Catalyst Wire Dossier

MF59-adjuvanted influenza vaccine

influenza vaccine adjuvanted with MF59 · Seqirus
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for MF59-adjuvanted influenza vaccine, covering 2013-06-05 to 2024-10-10. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults [Phase 2]

See pricing